Aerovate Therapeutics Inc... (AVTE)
Aerovate Therapeutics Max Pain By Strike
AVTE trades at $2.68, 7.2% above the near-term max pain of $2.5 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($2.5-$2.5), signaling increased put positioning or downside protection. Key magnetic zone at 3 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Aerovate Therapeutics Max Pain By Expiry
Max pain for AVTE shows a downward trend from 2.5 to 2.5, indicating bearish sentiment or hedging activity. The 0% spread suggests strong consensus on fair value. Most levels below 2.68 may cap rallies. Strong magnetic level at 3 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Aug 15, 2025 | 2.5 | -0.18 (-6.72%) |
| Nov 21, 2025 | 2.5 | -0.18 (-6.72%) |
| Jan 15, 2027 | 2.5 | -0.18 (-6.72%) |